Postbiotics Market worth $224.8 million by 2030- Exclusive Report by MarketsandMarkets™
The demand for postbiotics is projected to rise significantly, driven by growing consumer interest in microbiome health and the inherent limitations of probiotics and prebiotics in terms of viability and stability. Postbiotics, composed of non-living microbial cells and metabolites, offer proven health benefits without the need for live microorganisms. Their high stability under extreme processing conditions makes them ideal for a wide range of product formulations, including shelf-stable dietary supplements, functional foods, and beverages. Heat-treated bacterial strains, most notably Lactobacillus and Bifidobacterium, are widely recognized for their safety and scientifically supported benefits in gut, immune, and skin health. As consumer demand for microbiome-friendly solutions continues to grow, postbiotics are well-positioned to capture a larger share of the biotics market.
Browse in-depth TOC on "postbiotics Market"
250– Tables30– Figures200– Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237110254
Postbiotics in dry form to account for the fastest growth during the forecast period
Postbiotic powders are versatile forms and attractive to consumers; they are expected to be the most rapidly growing during the forecast period because postbiotic powders offer a highly concentrated dose of bioactive compounds that can be easily incorporated into multiple food and drink formats such as smoothies, cereals, and snack bars-a boon for modern lifestyles with taste and convenience intact. From a manufacturing perspective, their dry, heat-stable nature makes it easy to process them without major modifications to existing equipment or product systems. In addition, the increasing disillusionment of consumers with conventional pills has made powders, gummies, and bars alternative delivery formats all the more popular. Although live probiotics may fail in such formats, postbiotics overcome this hurdle, much more so in dry form, making them the best solution for the manufacturers as well as health-conscious consumers. This combination of formulation ease, shelf stability, and growing end-user preference underlines why dry form postbiotics are expected to witness the steepest growth in future years.
Cosmetics and personal care products segment to hold greater market share during the forecast period
The trend of skinimalism increasingly embraces everything simple and multifunctional in skincare, thereby rapidly increasing the demand for postbiotics. Postbiotics address numerous benefits within a singular formulation. They have been introduced into cosmetics such as moisturizing creams intended to restore the hydrolipid barrier, anti-aging serums, and hair care containing agents that strengthen the scalp and improve hair condition. Coupling their multifunctionality with safety and stability makes postbiotics suitable for sensitive, acne-prone, or otherwise problematic skin. They do not pose the risk of microbial overgrowth as live probiotics do, making them ideal for products aimed at restoring the skin's natural microbiome balance. With increasing eco-awareness and health-consciousness among consumers, and as interest rises in Clean Beauty and microbiome-friendly skincare, especially into 2025, postbiotics are expected to establish themselves as the active ingredient of choice within modern beauty. The anti-inflammatory, antioxidant, and barrier-supporting qualities of postbiotics thus enhance their efficacy and safety and have driven the postbiotic to ever-rising prominence in next-generation cosmetics and personal care products.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=237110254
European region to hold a significant market share in the global postbiotics market
Most of the European consumers now claim to use dietary supplements, which reveals the growing trend toward preventive health and wellness. Growing consumer engagement creates a conducive environment for the postbiotic markets as people turn to scientifically validated, gut-friendly sources for postbiotics that can be easily incorporated into daily routines through supplements and functional foods. Active participation of the major regional players with respect to Associated British Foods plc (UK), can also be the reason of European postbiotic growth. In November 2023, AB Biotek Human Nutrition & Health (UK), subsidiary of ABF (UK) sealed a partnership deal with Tetra Pak (Switzerland) to come up with innovative postbiotic solutions for food & beverage, making it easy to incorporate postbiotics into mainstream products such as dairy, plant-based drinks, and snacks without any special equipment for their manufacturing. Such partnerships widen the simplicity of the formulation of products and visibility and accessibility of postbiotic-enriched offerings. With this innovation, seen by one of the dominant European players, ABF (UK), bringing postbiotics closer to consumers through the most consumed formats, public awareness is anticipated to grow quickly, and the market is expected to expand across the region.
The report profiles key players such as Cargill, Incorporated (US), ADM (US), Kerry Group PLC (Ireland), dsm-firmenich (Netherlands), Associated British Foods plc (UK), BASF (Germany), Novozymes A/S, part of Novonesis Group (Denmark), International Flavors & Fragrances Inc (US), MCLS Europe B.V. (Netherlands), Phileo by Lesaffre (France), Lallemand Inc. (Canada), Sami-Sabinsa Group. (India), CJ CheilJedang Corp. (South Korea), Biotenova Sdn. Bhd. (Malaysia), and Bioprox Healthcare (France).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=237110254
Browse Adjacent Reports @ Food and Beverage Market Research Reports & Consulting
Related Reports:
Functional Food Ingredients Market by Type (Probiotics, Protein & Amino Acids, Phytochemicals & Plant Extracts, Prebiotics, Omega-3 Fatty Acids, Carotenoids, Vitamins), Application, Source, Form, Health Benefits and Region - Global Forecast to 2029
Probiotics Market Size, Share, Analysis, & Growth Trends Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Global Forecast to 2029
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets Inc.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@marketsandmarkets.comResearch Insight: https://www.marketsandmarkets.com/ResearchInsight/postbiotics-market.aspVisit Our Website: https://www.marketsandmarkets.com/Content Source: https://www.marketsandmarkets.com/PressReleases/postbiotics.asp
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/postbiotics-market-worth-224-8-million-by-2030-exclusive-report-by-marketsandmarkets-302515946.html
SOURCE MarketsandMarkets
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
BrightSpring Health Services Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
BrightSpring Health Services (NASDAQ:BTSG) Second Quarter 2025 Results Key Financial Results Revenue: US$3.15b (up 15% from 2Q 2024). Net income: US$9.21m (down 54% from 2Q 2024). Profit margin: 0.3% (down from 0.7% in 2Q 2024). EPS: US$0.046 (down from US$0.10 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period BrightSpring Health Services Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 5.3%. Earnings per share (EPS) missed analyst estimates by 9.3%. Looking ahead, revenue is forecast to grow 10.0% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Healthcare industry in the US. Performance of the American Healthcare industry. The company's shares are down 4.3% from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 3 warning signs for BrightSpring Health Services (of which 1 is a bit unpleasant!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Universal Display Second Quarter 2025 Earnings: Beats Expectations
Universal Display (NASDAQ:OLED) Second Quarter 2025 Results Key Financial Results Revenue: US$171.8m (up 8.4% from 2Q 2024). Net income: US$67.3m (up 29% from 2Q 2024). Profit margin: 39% (up from 33% in 2Q 2024). The increase in margin was primarily driven by higher revenue. EPS: US$1.41 (up from US$1.10 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Universal Display Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 6.8%. Earnings per share (EPS) also surpassed analyst estimates by 21%. Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Semiconductor industry in the US. Performance of the American Semiconductor industry. The company's shares are down 2.8% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Universal Display's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Altice USA, Inc. (ATUS) Secures $1B Loan Backed by NYC Network Assets
We recently compiled a list of the 10 Best Low Cost Stocks To Buy Under $50. Altice USA, Inc. stands fifth on our list. Altice USA, Inc. (NYSE:ATUS), one of the largest broadband and video service providers in the U.S., serves around 4.5 million customers across 21 states under the Optimum brand. It also operates Optimum Media for advertising solutions and News 12 for hyperlocal news coverage. In a significant move, the company announced a $1 billion asset-backed loan facility on July 17, 2025, secured by its Hybrid-Fiber Coaxial (HFC) network assets in the Bronx and Brooklyn. Partnering with Goldman Sachs and TPG Angelo Gordon, this marks a strategic shift toward infrastructure-backed financing. By monetizing physical network assets, Altice USA, Inc. (NYSE:ATUS) aims to unlock liquidity for reinvestment without diluting equity or relying on traditional debt, strengthening its financial position. A sleek broadband amplifier reflecting the rays of light in a server room. This financing strategy aligns with the growing demand for high-speed internet and underscores the importance of maintaining and upgrading broadband infrastructure. It also reflects a broader industry trend of telecom companies leveraging physical assets to support growth and competitiveness. Altice USA, Inc. (NYSE:ATUS) is set to release its Q2 2025 earnings on August 7, which will offer deeper insights into the company's progress. While we acknowledge the potential of ATUS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data